Risk scores for 30-day mortality after percutaneous coronary intervention: new insights into causes and risk of death

Mandeep Singh1, Ryan J Lennon2, Rajiv Gulati1

  • 1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.

Insights

The New York State Risk Score and Mayo Clinic Risk Score offer similar predictions for death after percutaneous coronary interventions (PCI). The highest risk of mortality occurs within the first two weeks post-PCI, primarily due to cardiac causes.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Health Outcomes Research

Background:

  • Percutaneous coronary interventions (PCIs) are common procedures for treating coronary artery disease.
  • Accurate risk stratification is crucial for patient management and outcomes after PCI.
  • Existing risk scores require validation in diverse patient populations and clinical settings.

Purpose of the Study:

  • To evaluate the causes and mortality risk following PCIs.
  • To compare the predictive performance of the New York State Risk Score (NYSRS) against the Mayo Clinic Risk Score (MCRS).
  • To validate the NYSRS using recalibrated probabilities in a separate patient cohort.

Main Methods:

  • A retrospective analysis of 4898 patients undergoing PCI at Mayo Clinic between 2007 and 2010.
  • In-hospital and 30-day mortality rates were assessed.
  • Receiver operating characteristic (ROC) curves were used to compare the discriminatory power of NYSRS and MCRS.

Main Results:

  • Overall in-hospital mortality was 1.9% and 30-day post-discharge mortality was 0.7%.
  • Both NYSRS and MCRS demonstrated excellent discrimination (Area Under Curve >0.88).
  • The highest risk of death occurred within the first 3 days post-PCI, with cardiac causes predominating, especially within the first week.

Conclusions:

  • The discriminatory performance of NYSRS and MCRS for predicting mortality after PCI is comparable.
  • The risk of death is most significant in the initial two weeks following PCI.
  • Cardiac events, particularly myocardial infarction, are the leading cause of death in the early post-PCI period.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
973
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444